117 related articles for article (PubMed ID: 3658567)
21. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
McGough JJ; Wigal SB; Abikoff H; Turnbow JM; Posner K; Moon E
J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
[TBL] [Abstract][Full Text] [Related]
22. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
[TBL] [Abstract][Full Text] [Related]
23. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
Marcus SC; Wan GJ; Kemner JE; Olfson M
Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
[TBL] [Abstract][Full Text] [Related]
24. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
Coghill DR; Rhodes SM; Matthews K
Biol Psychiatry; 2007 Nov; 62(9):954-62. PubMed ID: 17543895
[TBL] [Abstract][Full Text] [Related]
25. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
26. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
Varley CK; Trupin EW
Am J Ment Defic; 1982 May; 86(6):560-6. PubMed ID: 7102728
[TBL] [Abstract][Full Text] [Related]
27. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
Swanson J; Gupta S; Guinta D; Flynn D; Agler D; Lerner M; Williams L; Shoulson I; Wigal S
Clin Pharmacol Ther; 1999 Sep; 66(3):295-305. PubMed ID: 10511066
[TBL] [Abstract][Full Text] [Related]
28. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
[TBL] [Abstract][Full Text] [Related]
29. Attention deficit disorder with hyperactivity: differential effects of methylphenidate on impulsivity.
Rapport MD; DuPaul GJ; Stoner G; Birmingham BK; Masse G
Pediatrics; 1985 Dec; 76(6):938-43. PubMed ID: 4069863
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
[TBL] [Abstract][Full Text] [Related]
31. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
Medori R; Ramos-Quiroga JA; Casas M; Kooij JJ; Niemelä A; Trott GE; Lee E; Buitelaar JK
Biol Psychiatry; 2008 May; 63(10):981-9. PubMed ID: 18206857
[TBL] [Abstract][Full Text] [Related]
32. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
Fallu A; Richard C; Prinzo R; Binder C
Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
[TBL] [Abstract][Full Text] [Related]
33. Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings.
Gadow KD; Nolan EE; Sverd J; Sprafkin J; Paolicelli L
J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):710-8. PubMed ID: 2228923
[TBL] [Abstract][Full Text] [Related]
34. Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings.
Gadow KD; Nolan EE; Sverd J
J Am Acad Child Adolesc Psychiatry; 1992 May; 31(3):462-71. PubMed ID: 1592778
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of methylphenidate on ADD girls and ADD boys.
Pelham WE; Walker JL; Sturges J; Hoza J
J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):773-6. PubMed ID: 2676966
[TBL] [Abstract][Full Text] [Related]
36. Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity.
Swanson J; Kinsbourne M; Roberts W; Zucker K
Pediatrics; 1978 Jan; 61(1):21-9. PubMed ID: 400817
[TBL] [Abstract][Full Text] [Related]
37. Individual responses to methylphenidate and caffeine in children with minimal brain dysfunction.
Garfinkel BD; Webster CD; Sloman L
Can Med Assoc J; 1975 Oct; 113(8):729-32. PubMed ID: 803184
[TBL] [Abstract][Full Text] [Related]
38. Attention deficit disorder and methylphenidate: a multilevel analysis of dose-response effects on children's impulsivity across settings.
Rapport MD; Stoner G; DuPaul GJ; Kelly KL; Tucker SB; Schoeler T
J Am Acad Child Adolesc Psychiatry; 1988 Jan; 27(1):60-9. PubMed ID: 3343208
[No Abstract] [Full Text] [Related]
39. Methylphenidate and children with attention deficit disorder. Dose effects on classroom academic and social behavior.
Pelham WE; Bender ME; Caddell J; Booth S; Moorer SH
Arch Gen Psychiatry; 1985 Oct; 42(10):948-52. PubMed ID: 3899046
[TBL] [Abstract][Full Text] [Related]
40. Aggressive, prosocial, and nonsocial behavior in hyperactive boys: dose effects of methylphenidate in naturalistic settings.
Hinshaw SP; Henker B; Whalen CK; Erhardt D; Dunnington RE
J Consult Clin Psychol; 1989 Oct; 57(5):636-643. PubMed ID: 2794184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
